Literature DB >> 10618307

beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis.

X J Du1, D J Autelitano, R J Dilley, B Wang, A M Dart, E A Woodcock.   

Abstract

BACKGROUND: Beta-adrenergic signaling is downregulated in the failing heart, and the significance of such change remains unclear. METHODS AND
RESULTS: To address the role of beta-adrenergic dysfunction in heart failure (HF), aortic stenosis (AS) was induced in wild-type (WT) and transgenic (TG) mice with cardiac targeted overexpression of beta(2)-adrenergic receptors (ARs), and animals were studied 9 weeks later. The extents of increase in systolic arterial pressure (P<0.01 versus controls), left ventricular (LV) hypertrophy (TG, 94+/-6 to 175+/-7 mg; WT, 110+/-6 to 168+/-10 mg; both P<0.01), and expression of ANP mRNA were similar between TG and WT mice with AS. TG mice had higher incidences of premature death and critical illness due to heart failure (75% versus 23%), pleural effusion (81% versus 45%), and left atrial thrombosis (81% versus 36%, all P<0.05). A more extensive focal fibrosis was found in the hypertrophied LV of TG mice (P<0.05). These findings indicate a more severe LV dysfunction in TG mice. In sham-operated mice, LV dP/dt(max) and heart rate were markedly higher in TG than WT mice (both P<0.01). dP/dt(max) was lower in both AS groups than in sham-operated controls, and this tended to be more pronounced in TG than WT mice (-32+/-5% versus -16+/-6%, P=0.059), although dP/dt(max) remained higher in TG than WT groups (P<0.05).
CONCLUSIONS: Elevated cardiac beta-adrenergic activity by beta(2)-AR overexpression leads to functional deterioration after pressure overload.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618307     DOI: 10.1161/01.cir.101.1.71

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice.

Authors:  Xiao-Jun Du; Timothy J Cole; Nora Tenis; Xiao-Ming Gao; Frank Köntgen; Bruce E Kemp; Jörg Heierhorst
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  β₂-Adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another 'radical' road to heart failure?

Authors:  Fabio Di Lisa; Nina Kaludercic; Nazareno Paolocci
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  Targeting calcium cycling proteins in heart failure through gene transfer.

Authors:  Federica del Monte; Roger J Hajjar
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

4.  Ventricular function during exercise in mice and rats.

Authors:  Heidi L Lujan; Hussein Janbaih; Han-Zhong Feng; Jian-Ping Jin; Stephen E DiCarlo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-19       Impact factor: 3.619

Review 5.  Gene therapy in heart failure.

Authors:  Leif Erik Vinge; Philip W Raake; Walter J Koch
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 6.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

Review 7.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

8.  Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes.

Authors:  Mingming Zhao; Giovanni Fajardo; Takashi Urashima; Joshua M Spin; Sara Poorfarahani; Viswanathan Rajagopalan; Diem Huynh; Andrew Connolly; Thomas Quertermous; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

9.  The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.

Authors:  O F Bueno; L J De Windt; K M Tymitz; S A Witt; T R Kimball; R Klevitsky; T E Hewett; S P Jones; D J Lefer; C F Peng; R N Kitsis; J D Molkentin
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

Review 10.  Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure?

Authors:  Samuel Lee; Robert H G Schwinger; Klara Brixius
Journal:  Pflugers Arch       Date:  2007-09-14       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.